急性胸痛患者CT衍生左心房与左心室测量指标的预后价值
回顾性分析225例因急性胸痛行冠状动脉CT血管成像的患者,测量左心房直径、左心室质量等心脏CT指标,随访中位13个月,42例(18.7%)发生主要不良心脏事件。控制Framingham风险评分后,左心房直径(HR 1.07/mm)和左心室质量(HR 1.05/g)仍为MACE的显著预后因素,且两者相互独立。
要点
- 左心房直径每增加1mm,MACE风险HR为1.07(95%CI 1.01-1.13)。
- 左心室质量每增加1g,MACE风险HR为1.05(95%CI 1.00-1.10)。
- 左心房直径与左心室质量的预后价值相互独立,且独立于传统风险因素、冠状动脉钙化评分及 obstructive 冠状动脉疾病。
核心结论
- CT衍生的左心房直径和左心室质量与急性胸痛患者未来主要不良心脏事件相关,并具有超越传统风险因素、冠状动脉钙化评分和梗阻性冠状动脉疾病的独立预后价值。
研究设计与样本
- 回顾性分析,225例受试者(年龄56.2±11.2岁,男性140例),因急性胸痛评估行双源CT冠状动脉CT血管成像,测量左心室质量、左心室射血分数、左心室收缩末期容积和舒张末期容积、左心房收缩末期容积和左心房直径、室间隔厚度及心腔直径;MACE定义为心源性死亡、非致死性心肌梗死、不稳定型心绞痛或晚期血运重建;采用Cox比例风险分析。
诊断标准与关键数值
- 左心房直径每增加1mm,MACE的HR为1.07(95%CI 1.01-1.13),控制Framingham风险评分后仍显著。
- 左心室质量每增加1g,MACE的HR为1.05(95%CI 1.00-1.10),控制Framingham风险评分后仍显著。
- 左心房直径和左心室质量被发现在彼此独立的情况下仍具有预后价值。
- 其他形态学和功能学心脏测量指标对MACE无显著预后价值。
临床应用与阅片要点
- 在急性胸痛患者的CCTA图像上测量左心房直径和左心室质量,可能有助于识别MACE高风险患者。
- 左心房直径和左心室质量的预后价值独立于传统风险因素、冠状动脉钙化评分和梗阻性冠状动脉疾病。
- 作者结论认为CT衍生的左心房直径和左心室质量与未来MACE相关并具有独立预后价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine which left atrial (LA) and left ventricular (LV) parameters are associated with future major adverse cardiac event (MACE) and whether these measurements have independent prognostic value beyond risk factors and computed tomography (CT)-derived coronary artery disease measures.
MATERIALS AND METHODS: This retrospective analysis was performed under an IRB waiver and in HIPAA compliance. Subjects underwent coronary CT angiography (CCTA) using a dual-source CT system for acute chest pain evaluation. LV mass, LV ejection fraction (EF), LV end-systolic volume (ESV) and LV end-diastolic volume (EDV), LA ESV and LA diameter, septal wall thickness and cardiac chamber diameters were measured. MACE was defined as cardiac death, non-fatal myocardial infarction, unstable angina, or late revascularization. The association between cardiac CT measures and the occurrence of MACE was quantified using Cox proportional hazard analysis.
RESULTS: 225 subjects (age, 56.2±11.2; 140 males) were analyzed, of whom 42 (18.7%) experienced a MACE during a median follow-up of 13 months. LA diameter (HR:1.07, 95%CI:1.01-1.13permm) and LV mass (HR:1.05, 95%CI:1.00-1.10perg) remained significant prognostic factor of MACE after controlling for Framingham risk score. LA diameter and LV mass were also found to have prognostic value independent of each other. The other morphologic and functional cardiac measures were no significant prognostic factors for MACE.
CONCLUSION: CT-derived LA diameter and LV mass are associated with future MACE in patients undergoing evaluation for chest pain, and portend independent prognostic value beyond traditional risk factors, coronary calcium score, and obstructive coronary artery disease.
引用
- Takx RAP, Vliegenthart R, Schoepf UJ, et al. Prognostic value of CT-derived left atrial and left ventricular measures in patients with acute chest pain. Eur J Radiol. 2016. PMID: 28027742. doi:10.1016/j.ejrad.2016.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。